Burden of Illness
Health-Related Quality of Life
Healthcare Resource Utilization
Patient Reported Outcomes
Newly diagnosed advanced NSCLC pts with baseline Brain Metastases experienced a significantly faster and clinically meaningful deterioration in patient-reported outcomes (PRO) based health-related...
This study investigated the impact of pazopanib on mRCC patients’ health-related quality of life (HRQOL) in the US community oncology setting. Using real-world retrospective data, this study showed...
Despite curative treatment intent, most patients (pts) with unresected Stage III NSCLC progress to metastatic disease. Prior research has shown significant benefits on clinical outcomes when HRQoL is...
Targeted therapy is widely used in metastatic renal cell carcinoma (mRCC) to improve survival and health-related quality of life (HRQOL). This study investigated the impact of pazopanib on mRCC...
Treatment options for advanced non-squamous non-small cell lung cancer (NSCLC) in the first line include platinum-based doublet therapy with or without bevacizumab. This study examined efficacy...
We report findings from a prospective observational study that examined health-related quality of life (HRQOL) in patients newly diagnosed with advanced non-small cell lung cancer (NSCLC), with or...